Spironolactone Treatment for Ankle Edema

Introduction to Spironolactone

• The European Society of Cardiology recommends spironolactone as an appropriate choice for idiopathic ankle edema, particularly in patients without heart failure, with a typical starting dose of 25 mg once daily 2

Monitoring Requirements

• Regular laboratory monitoring of serum potassium and creatinine is essential before starting spironolactone, with checks at 1 week, 4 weeks, and then every 6 months thereafter, as recommended by the European Journal of Heart Failure 2
• If potassium rises to >5.5 mmol/L, the dose should be halved to 12.5 mg daily or 25 mg on alternate days, and if it rises to ≥6.0 mmol/L, spironolactone should be stopped immediately, according to the European Journal of Heart Failure 2

Important Drug Interactions

• The European Journal of Heart Failure advises against combining spironolactone with certain medications, such as potassium supplements, salt substitutes containing potassium, or high-potassium diets, and recommends caution with NSAIDs, which can increase hyperkalemia risk 2

Risk Factors and Complications

• Patients with risk factors such as age >65 years, diabetes, renal insufficiency, and dehydration require extra caution and closer monitoring, with a daily dose not exceeding 25 mg, as recommended by the European Journal of Heart Failure 2

Practical Implementation

• The European Journal of Heart Failure suggests starting with the lowest effective dose of 25 mg once daily and monitoring closely, with expectations of gradual improvement in ankle edema over 2-4 weeks 2

Adverse Effects

• Significant dizziness or lightheadedness, although unlikely at 25 mg daily, should be reported immediately to the physician, according to the European Journal of Heart Failure 3
• Breast tenderness or enlargement, which occurs in ~10% of men on spironolactone, should also be reported to the physician, as advised by the European Journal of Heart Failure 2